Clinical Trial Update: Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating memory-like natural killer cells following TCRαβ T cell-depleted haploidentical transplantation for acute myeloid leukemia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Memory-like natural killer (ML NK) cells

Snippet

Sponsor: Washington University School of Medicine | Conditions: AML, Childhood, Aml | Phase 1, Phase 2 | Status: RECRUITING